Heidelberg Engineering Names New Scientific Director

Charles Reisman has joined Heidelberg Engineering’s global management team as Scientific Director. In this newly created role, he will be responsible for the clinical research plan that directly feeds into the product development pipeline.

Mr. Reisman is an accomplished clinical validation expert with decades of ophthalmic industry and other high-technology expertise. He holds an Electrical Engineering degree from the Massachusetts Institute of Technology (MIT) and several patents on signal and image processing methodologies within the field of ophthalmic imaging. He has published in numerous distinguished peer-reviewed scientific journals and book chapters and is also well versed in deep learning and artificial intelligence.

In his new position, Mr. Reisman will focus on the strategic leadership of Heidelberg Engineering’s clinical research and trial efforts, ultimately geared towards executing the company’s product development pipeline. For that purpose, he will not only work closely with the Research and Development, Clinical and Regulatory Affairs teams, but primarily with external researchers from across the world.

“I look forward to contributing to Heidelberg Engineering’s product development goals within our heavily regulated environment. I am particularly inspired by the collaborations with leading clinicians and researchers across the world as well as the impressive team of R&D experts at Heidelberg Engineering, that are among the brightest in the industry,” Mr. Reisman said in a company news release.

“Charles brings excellent credentials and a deep understanding of the ophthalmic research and development landscape. We are confident that his expertise will help us bring more and even better products to the market. We are specifically focused on early detection of diseases by supporting the confident identification of clinical biomarkers,” said Arianna Schoess Vargas, Managing Director of Heidelberg Engineering.